Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-025929
Filing Date
2022-07-11
Accepted
2022-07-11 17:01:04
Documents
2
Period of Report
2022-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1572
2 EX-24 DOCUMENT attachment1.htm EX-24 3218
  Complete submission text file 0000899243-22-025929.txt   6192
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Epperly Melissa B, (Reporting) CIK: 0001807359 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 221077467